The changing role of economic evaluation in valuing medical technologies

Author： Rotter Jason S   Foerster Douglas   Bridges John FP  

Publisher： Informa Healthcare

ISSN： 1473-7167

Source： Expert Review of Pharmacoeconomics and Outcomes Research, Vol.12, Iss.6, 2012-12, pp. : 711-723

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Issues surrounding the health economic evaluation of genomic technologies

By Buchanan James   Wordsworth Sarah   Schuh Anna  

Pharmacogenomics, Vol. 14, Iss. 15, 2013-11 ,pp. : 1833-1847

Future Medicine

Access to resources Recommend Favorite

Valuing Prevention Through Economic Evaluation: Some Considerations Regarding the Choice of Discount Model for Health Effects with Focus on Infectious Diseases

By Jasper M. Bos   Philippe Beutels   Lieven Annemans   Maarten J. Postma  

PharmacoEconomics, Vol. 22, Iss. 18, 2004-01 ,pp. : 1171-1179

Adis International

Access to resources Recommend Favorite

Decision Analytic Modelling in the Economic Evaluation of Health Technologies: A Consensus Statement

By  

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 443-444

Adis International

Access to resources Recommend Favorite

Studying medical technologies

By Hadolt Bernhard  

Anthropology & Medicine, Vol. 19, Iss. 1, 2012-04 ,pp. : 49-50

Routledge Ltd

Access to resources Recommend Favorite

Transparency of Economic Evaluations of Health Technologies

By Rovira Joan  

PharmacoEconomics, Vol. 26, Iss. 3, 2008-01 ,pp. : 181-183

Adis International

Access to resources Recommend Favorite